000			03305nam a22003735i 4500
001			82379
003			ES-MaUEC
005			20230207040409.0
007			cr nn 008mamaa
008			150602s2015 gw | s |||| 0|eng d
020			_a9783319173320
024	7		_a10.1007/978-3-319-17332-0 _2doi
050		4	_aRC684.C48 _b2015 EB
245	1	0	_aPharmacological Treatment of Chronic Stable Angina Pectoris _cedited by Pablo Avanzas, Juan Carlos Kaski.
260			_aCham, Switzerland _bSpringer _c2015
300			_a1 recurso en línea (XI, 278 páginas) _b32 ilustraciones, 23 ilustraciones en color
336			_aTexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
490	0		_aCurrent Cardiovascular Therapy
505	0		_aMechanisms of angina -- An overview of treatment and guidelines “C /ACC-AHA/ NICE -- Beta-blockers -- Calcium channel blockers -- Nitrates -- Nicorandil -- Ivabradine. Trimetazidine -- Ranolazine -- New antianginal drugs still not available for clinical use -- Medical therapy versus revascularization in the management of stable angina pectoris.
520	3		_aThis book describes the clinical challenge currently posed by stable angina pectoris and provides guidance for those making clinical decisions regarding its pharmacological treatment. The importance of providing effective treatment is beyond dispute and this book deals with the most relevant aspects related to its pharmacological treatment. The pathogenesis of myocardial ischemia as the basis for rational treatment of angina is discussed thoroughly together with all major management goals including optimal symptom control and the secondary prevention of serious cardiovascular events. Pharmacological Treatment of Chronic Stable Angina Pectoris provides a clear description of the mechanisms of action and clinical indications of available anti-angina drugs and strategies for the use of novel pharmacological agents. It also includes a critical appraisal of the major management guidelines, which will assist the reader to interpret current evidence and provide the most appropriate forms of treatment. The ongoing controversy regarding medical therapy versus myocardial revascularization for the management of stable angina pectoris is also addressed. This eminently practical book will help guiding the reader through the complexities of the field and will be highly appreciated by clinicians, clinical cardiologists and cardiology trainees alike.
710	2		_aSpringerLink (Online service) _0Local _9106996
942			_2lcc _cLE
650		7	_aAngina de pecho _2embne _9144714
650		7	_9138557 _aCardiología _2embne
700	1		_aAvanzas, Pablo _eeditor literario _947108
700	1		_aKaski, Juan Carlos _eeditor literario _91559 _0comprobar BNE19972966812
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-3-319-17332-0 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
907			_a.b12910193 _b10-10-17 _c10-02-16
988			_aSpringer_Medicine_2015
998			_am _a_alco _a_vill _b - - _cm _dz _e- _feng _ggw _h0
945			_aRC684.C48 P437 2015 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11577873 _z06-04-17
999			_c82379 _d82379 _x1